摘要
乳腺癌是我国女性发病率最高的恶性肿瘤。随着乳腺癌综合治疗技术的进步和患者生存期的延长,为提高乳腺癌患者的生存质量,乳腺肿瘤整形外科受到越来越多的重视。乳腺肿瘤整形外科主要包括保乳整形和乳房重建两个技术体系。相较于西方发达国家,我国乳腺肿瘤整形外科虽起步较晚,但发展迅速,在很多领域都取得长足的进步。本文将就植入物乳房重建、自体组织乳房重建、脂肪移植乳房成形、内窥镜辅助乳房重建、乳头乳晕重建、患者报告结局评价等亚专科领域,对我国乳腺肿瘤整形外科的研究进展、当前学科发展的不足之处,及未来发展方向进行综述。
Breast cancer is the most common malignancy among women in China.Due to the advancement in systemic interventions,the survival of patients with breast cancer has remarkably improved.In particular,oncoplastic breast surgery has gained momentum due to its positive impact on patients’quality of life.Oncoplastic breast conservation surgery and postmastectomy breast reconstruction are the two main branches of this frontier discipline.Although oncoplastic breast surgery gained scholarly attention in China later than in Western countries,considerable development and progress has been made over the last few decades.Here,we aimed to summarize the academic achievements of Chinese oncoplastic surgeons in implant-based breast reconstruction,autologous tissue breast reconstruction,mammoplasty by lipofilling,endoscope-assisted breast reconstruction,and nipple-areola reconstruction.we also summarized patient-reported outcomes.The drawbacks of the current investigations will be discussed along with the directions for future clinical practice and research.
作者
殷竹鸣
尹健
Zhuming Yin;Jian Yin(Department of Breast Oncoplastic Surgery,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer(Tianjin),Key Laboratory of Breast Cancer Prevention and Therapy,Ministry of Education,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Sino-Russian Joint Research Center for Oncoplastic Breast Surgery,Tianjin 300060,China)
出处
《中国肿瘤临床》
CAS
CSCD
北大核心
2020年第5期245-248,共4页
Chinese Journal of Clinical Oncology
基金
国家自然科学基金项目(编号:81703167)
天津市科技计划项目(编号:18PTZWHZ00050)资助。
关键词
乳腺癌
乳腺外科
肿瘤整形外科
乳房重建
breast cancer
breast surgery
oncoplastic surgery
breast reconstruction